Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 2
2008 3
2009 2
2010 5
2011 8
2012 5
2013 10
2014 4
2015 3
2016 2
2017 2
2018 6
2019 2
2020 2
2021 6
2022 5
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Hepatitis C virus RNA is 5'-capped with flavin adenine dinucleotide.
Sherwood AV, Rivera-Rangel LR, Ryberg LA, Larsen HS, Anker KM, Costa R, Vågbø CB, Jakljevič E, Pham LV, Fernandez-Antunez C, Indrisiunaite G, Podolska-Charlery A, Grothen JER, Langvad NW, Fossat N, Offersgaard A, Al-Chaer A, Nielsen L, Kuśnierczyk A, Sølund C, Weis N, Gottwein JM, Holmbeck K, Bottaro S, Ramirez S, Bukh J, Scheel TKH, Vinther J. Sherwood AV, et al. Among authors: gottwein jm. Nature. 2023 Jul;619(7971):811-818. doi: 10.1038/s41586-023-06301-3. Epub 2023 Jul 5. Nature. 2023. PMID: 37407817
Toward a vaccine against hepatitis C virus.
Offersgaard A, Bukh J, Gottwein JM. Offersgaard A, et al. Among authors: gottwein jm. Science. 2023 Apr 7;380(6640):37-38. doi: 10.1126/science.adf2226. Epub 2023 Apr 6. Science. 2023. PMID: 37023205
Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants.
Jensen SB, Fahnøe U, Pham LV, Serre SBN, Tang Q, Ghanem L, Pedersen MS, Ramirez S, Humes D, Pihl AF, Filskov J, Sølund CS, Dietz J, Fourati S, Pawlotsky JM, Sarrazin C, Weis N, Schønning K, Krarup H, Bukh J, Gottwein JM. Jensen SB, et al. Among authors: gottwein jm. Hepatology. 2019 Sep;70(3):771-787. doi: 10.1002/hep.30647. Epub 2019 Jun 5. Hepatology. 2019. PMID: 30964552 Free PMC article. Review.
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2.
Zhou Y, Gilmore K, Ramirez S, Settels E, Gammeltoft KA, Pham LV, Fahnøe U, Feng S, Offersgaard A, Trimpert J, Bukh J, Osterrieder K, Gottwein JM, Seeberger PH. Zhou Y, et al. Among authors: gottwein jm. Sci Rep. 2021 Jul 16;11(1):14571. doi: 10.1038/s41598-021-93361-y. Sci Rep. 2021. PMID: 34272426 Free PMC article.
Identification of novel neutralizing determinants for protection against HCV.
Alzua GP, Pihl AF, Offersgaard A, Velázquez-Moctezuma R, Duarte Hernandez CR, Augestad EH, Fahnøe U, Mathiesen CK, Krarup H, Law M, Prentoe J, Bukh J, Gottwein JM. Alzua GP, et al. Among authors: gottwein jm. Hepatology. 2023 Mar 1;77(3):982-996. doi: 10.1002/hep.32772. Epub 2023 Feb 17. Hepatology. 2023. PMID: 36056620 Free PMC article.
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system.
Zhou Y, Gammeltoft KA, Ryberg LA, Pham LV, Tjørnelund HD, Binderup A, Duarte Hernandez CR, Fernandez-Antunez C, Offersgaard A, Fahnøe U, Peters GHJ, Ramirez S, Bukh J, Gottwein JM. Zhou Y, et al. Among authors: gottwein jm. Sci Adv. 2022 Dec 21;8(51):eadd7197. doi: 10.1126/sciadv.add7197. Epub 2022 Dec 21. Sci Adv. 2022. PMID: 36542720 Free PMC article.
SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor.
Offersgaard A, Duarte Hernandez CR, Pihl AF, Costa R, Venkatesan NP, Lin X, Van Pham L, Feng S, Fahnøe U, Scheel TKH, Ramirez S, Reichl U, Bukh J, Genzel Y, Gottwein JM. Offersgaard A, et al. Among authors: gottwein jm. Vaccines (Basel). 2021 Jun 29;9(7):706. doi: 10.3390/vaccines9070706. Vaccines (Basel). 2021. PMID: 34209694 Free PMC article.
67 results